<VariationArchive VariationID="1098750" VariationName="NM_025114.4(CEP290):c.384_385del (p.Asp128fs)" VariationType="Deletion" Accession="VCV001098750" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-12" DateCreated="2021-05-23" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1087539" VariationID="1098750">
      <GeneList>
        <Gene Symbol="CEP290" FullName="centrosomal protein 290" GeneID="80184" HGNC_ID="HGNC:29021" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="88049016" stop="88142088" display_start="88049016" display_stop="88142088" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="88442789" stop="88535992" display_start="88442789" display_stop="88535992" Strand="-" />
          </Location>
          <OMIM>610142</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025114.4(CEP290):c.384_385del (p.Asp128fs)</Name>
      <CanonicalSPDI>NC_000012.12:88136698:TAT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q21.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="88136699" stop="88136700" display_start="88136699" display_stop="88136700" variantLength="2" positionVCF="88136698" referenceAlleleVCF="CTA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="88530476" stop="88530477" display_start="88530476" display_stop="88530477" variantLength="2" positionVCF="88530475" referenceAlleleVCF="CTA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D128fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.88530477_88530478del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.88530477_88530478del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.88136700_88136701del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.88136700_88136701del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008417.2" sequenceAccession="NG_008417" sequenceVersion="2" change="g.10517_10518del">
            <Expression>NG_008417.2:g.10517_10518del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025114.4" sequenceAccession="NM_025114" sequenceVersion="4" change="c.384_385del" MANESelect="true">
            <Expression>NM_025114.4:c.384_385del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079390.3" sequenceAccession="NP_079390" sequenceVersion="3" change="p.Asp128fs">
            <Expression>NP_079390.3:p.Asp128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_694" sequenceAccession="LRG_694">
            <Expression>LRG_694:g.10517_10518del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_694t1" sequenceAccession="LRG_694t1">
            <Expression>LRG_694t1:c.384_385del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_694p1" sequenceAccession="LRG_694p1" change="p.Asp128fs">
            <Expression>LRG_694p1:p.Asp128fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1288619268" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025114.4(CEP290):c.384_385del (p.Asp128fs) AND CEP290-related disorder" Accession="RCV001420743" Version="1">
        <ClassifiedConditionList TraitSetID="33525">
          <ClassifiedCondition DB="MedGen" ID="CN239314">CEP290-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-21" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025114.4(CEP290):c.384_385del (p.Asp128fs) AND Bardet-Biedl syndrome 14" Accession="RCV003469783" Version="1">
        <ClassifiedConditionList TraitSetID="363">
          <ClassifiedCondition DB="MedGen" ID="C2673874">Bardet-Biedl syndrome 14</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025114.4(CEP290):c.384_385del (p.Asp128fs) AND multiple conditions" Accession="RCV003771340" Version="1">
        <ClassifiedConditionList TraitSetID="22840">
          <ClassifiedCondition DB="MedGen" ID="C0431399">Familial aplasia of the vermis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0265215">Meckel-Gruber syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-31" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-23" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16909394</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17345604</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20683928</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20690115</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26062849</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31877679</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34196655</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-29">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="22840" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="1878" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CEREBELLOPARENCHYMAL DISORDER IV</ElementValue>
                <XRef Type="MIM" ID="213300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial aplasia of the vermis</ElementValue>
                <XRef ID="Familial+aplasia+of+the+vermis/8373" DB="Genetic Alliance" />
                <XRef ID="253175003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Joubert syndrome</ElementValue>
                <XRef ID="MONDO:0018772" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS213300" DB="OMIM" />
                <XRef ID="716997004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebelloparenchymal disorder 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Joubert-Boltshauser syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JBTS</ElementValue>
                <XRef Type="MIM" ID="213300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6802" />
                <XRef ID="6802" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Classic Joubert syndrome (JS) is characterized by three primary findings: A distinctive cerebellar and brain stem malformation called the molar tooth sign (MTS). Hypotonia. Developmental delays. Often these findings are accompanied by episodic tachypnea or apnea and/or atypical eye movements. In general, the breathing abnormalities improve with age, truncal ataxia develops over time, and acquisition of gross motor milestones is delayed. Cognitive abilities are variable, ranging from severe intellectual disability to normal. Additional findings can include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. Both intra- and interfamilial variation are seen.</Attribute>
                <XRef ID="NBK1325" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301500</ID>
                <ID Source="BookShelf">NBK1325</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21448235</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="475" DB="Orphanet" />
              <XRef ID="C0431399" DB="MedGen" />
              <XRef ID="MONDO:0018772" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS213300" DB="OMIM" />
            </Trait>
            <Trait ID="2736" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DYSENCEPHALIA SPLANCHNOCYSTICA</ElementValue>
                <XRef Type="MIM" ID="249000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gruber syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dysencephalia splachnocystica</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Meckel-Gruber syndrome</ElementValue>
                <XRef ID="29076005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MKS</ElementValue>
                <XRef Type="MIM" ID="249000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MES</ElementValue>
                <XRef Type="MIM" ID="249000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3436" />
                <XRef ID="3436" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="564" DB="Orphanet" />
              <XRef ID="C0265215" DB="MedGen" />
              <XRef ID="MONDO:0018921" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS249000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33525" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36511" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CEP290-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CEP290-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CEP290-related condition</ElementValue>
              </Name>
              <XRef ID="CN239314" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="363" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="8926" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bardet-Biedl syndrome 14</ElementValue>
                <XRef ID="MONDO:0014442" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BBS14</ElementValue>
                <XRef Type="MIM" ID="615991" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16038" />
                <XRef ID="16038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301537</ID>
                <ID Source="BookShelf">NBK1363</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2010">
                <ID Source="pmc">3061994</ID>
              </Citation>
              <XRef ID="110" DB="Orphanet" />
              <XRef ID="C2673874" DB="MedGen" />
              <XRef ID="MONDO:0014442" DB="MONDO" />
              <XRef Type="MIM" ID="615991" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3194980" SubmissionDate="2021-05-19" DateLastUpdated="2021-05-23" DateCreated="2021-05-23">
        <ClinVarSubmissionID localKey="NM_025114.3:c.384_385delTA|CEP290-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001623086" DateUpdated="2021-05-23" DateCreated="2021-05-23" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26062849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20683928</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20690115</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31877679</ID>
          </Citation>
          <Comment>Variant summary: CEP290 c.384_385delTA (p.Asp128GlufsX17) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations around- and downstream of this position have been reported in affected individuals (HGMD). The variant allele was found at a frequency of 4e-06 in 249066 control chromosomes (gnomAD). The variant, c.384_385delTA, has been reported in the literature in at least two compound heterozygous individuals who were affected with isolated (i.e. non-syndromic) Leber congenital amaurosis (Coppieters_2010) and pericentral retinitis pigmentosa (Karali_2019); these phenotypes represent the least severe end of the CEP290 associated disease spectrum (Coppieters_2010b, Drivas_2015). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEP290" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025114.3:c.384_385delTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CEP290-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9683184</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7865497" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_025114.4:c.384_385del|OMIM:615991" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004216575" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025114.4:c.384_385del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615991" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8525940" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="4908242|MedGen:C0431399;C0265215;C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004570830" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20683928</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34196655</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16909394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17345604</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20690115</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1098750). This premature translational stop signal has been observed in individual(s) with retinal dystrophy (PMID: 20683928, 34196655). This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Asp128Glufs*17) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEP290" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.88530476_88530477del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0431399" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265215" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8525940" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7865497" TraitType="Disease" MappingType="XRef" MappingValue="615991" MappingRef="OMIM">
        <MedGen CUI="C2673874" Name="Bardet-Biedl syndrome 14" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8525940" TraitType="Disease" MappingType="XRef" MappingValue="C0431399" MappingRef="MedGen">
        <MedGen CUI="C0431399" Name="Familial aplasia of the vermis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3194980" TraitType="Disease" MappingType="Name" MappingValue="CEP290-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="CN239314" Name="CEP290-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8525940" TraitType="Disease" MappingType="XRef" MappingValue="C0265215" MappingRef="MedGen">
        <MedGen CUI="C0265215" Name="Meckel-Gruber syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

